What is LOPJLB’s current signal on SUPN?

LOPJLB’s latest quantitative signal on Supernus Pharmaceuticals, Inc. (SUPN) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is SUPN in?

Supernus Pharmaceuticals, Inc. (SUPN) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Supernus Pharmaceuticals, Inc. (SUPN) do?

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of marketed products includes Trokendi XR, an extended-release topiramate formulation prescribed for both epilepsy management and migraine prevention. Another key product is Oxtellar XR, an extended-release …